Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Absci (ABSI) Research & Development (2020 - 2025)

Historic Research & Development for Absci (ABSI) over the last 6 years, with Q3 2025 value amounting to $19.2 million.

  • Absci's Research & Development rose 702.81% to $19.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $74.4 million, marking a year-over-year increase of 2891.21%. This contributed to the annual value of $63.9 million for FY2024, which is 3285.41% up from last year.
  • According to the latest figures from Q3 2025, Absci's Research & Development is $19.2 million, which was up 702.81% from $20.5 million recorded in Q2 2025.
  • Absci's Research & Development's 5-year high stood at $20.5 million during Q2 2025, with a 5-year trough of $7.0 million in Q1 2021.
  • Its 5-year average for Research & Development is $14.3 million, with a median of $15.3 million in 2024.
  • Its Research & Development has fluctuated over the past 5 years, first surged by 39023.09% in 2021, then tumbled by 2895.97% in 2023.
  • Quarter analysis of 5 years shows Absci's Research & Development stood at $15.8 million in 2021, then fell by 28.23% to $11.3 million in 2022, then grew by 8.43% to $12.3 million in 2023, then soared by 49.78% to $18.4 million in 2024, then increased by 4.75% to $19.2 million in 2025.
  • Its last three reported values are $19.2 million in Q3 2025, $20.5 million for Q2 2025, and $16.4 million during Q1 2025.